|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Part 7: Immunodysfunction and Peritonitis in PD |
Chronic Disease Research Group, Minneapolis, Minnesota and University of Minnesota, Minneapolis, Minnesota, U.S.A.
Correspondence to: Robert N. Foley, Chronic Disease Research Group, 914 South
8th Street, Suite S-430, Minneapolis, Minnesota 55404
U.S.A.
RFoley{at}cdrg.org
Surprisingly little formal research has examined the issue of major
bacterial infections in chronic dialysis patients. This is a surprising
situation, because uremia is a classic state of immune hyporesponsiveness, and
infection rates are believed to be several times higher in dialysis
populations than in age-matched segments of the general population. The
present paper focuses on the clinical epidemiology of major bacterial
infections in dialysis patients, associations between bacterial infections and
cardiovascular disease, and interventions aimed at averting these
infections.
KEY WORDS: Pneumonia; septicemia; cardiovascular mortality.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |